Lamei Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lamei Zhou has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Guoqing Zhao
Department of Rheumatology, Wuxi Hospital of Traditional Chinese Medicine, Wuxi 214000, China
3 shared publicationsLu Jia
Department of Rheumatology, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, WuXi, China
2 shared publicationsXueni Lin
Department of Rheumatology, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, WuXi, China
2 shared publicationsXuhong Zhang
Department of Rheumatology, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, WuXi, China
2 shared publicationsCongying Ding
Department of Chemistry, Key Laboratory of Biomedical Functional Materials, School of Science, China Pharmaceutical University, Nanjing, People's Republic of China
1 shared publicationDongjian Zhang
Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China
1 shared publication
Latest Publications
- 3 February 2026
- Published by Elsevier in Fitoterapia
- Vol. 190, 107118
Si-Miao-Yong-An decoction restores macrophage efferocytosis and modulates vascular inflammation via PPAR-γ/MerTK pathway to treat atherosclerosis
- 3 February 2026
- Published by Elsevier in Fitoterapia
- Vol. 190, 107118
Si-Miao-Yong-An decoction restores macrophage efferocytosis and modulates vascular inflammation via PPAR-γ/MerTK pathway to treat atherosclerosis
- 1 December 2025
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 150 (24) , 5514-5524
V-Ti 3 C 2 nanozyme with peroxidase-like activity for dye removal and the colorimetric detection of Fe 3+
Preparation of V-Ti 3 C 2 and its application in dye adsorption and degradation, as well as Fe 3+ detection.
- 1 December 2025
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 150 (24) , 5514-5524
V-Ti 3 C 2 nanozyme with peroxidase-like activity for dye removal and the colorimetric detection of Fe 3+
Preparation of V-Ti 3 C 2 and its application in dye adsorption and degradation, as well as Fe 3+ detection.
- Open Access
- 18 November 2025
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 26 (1) , 12
The gut-bone axis in ankylosing spondylitis: mechanistic insights and the translational gap
The gut-bone axis is pivotal in the pathogenesis of ankylosing spondylitis (AS), with gut dysbiosis and mucosal immune activation driving skeletal pathology. However, translating these mechanistic insights into effective therapies remains challenging. This review critically analyzes this translational gap, arguing that the therapeutic paradoxes seen with cytokine inhibitors and microbiome-targeted therapies are a direct consequence of the disease's significant variability. We focus on the unexpected failure of IL-23 inhibitors and the dual effects of IL-17 blockade to illustrate the need for a nuanced understanding of tissue-specific immunity. We then propose a biomarker-driven, AI-assisted therapeutic framework that integrates multi-omic data to personalize AS treatment, aiming to bridge the gap between mechanistic insights and clinical success and offer a path toward progression-free remission.
- 18 November 2025
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 26 (1) , 12
Open AccessThe gut-bone axis in ankylosing spondylitis: mechanistic insights and the translational gap
The gut-bone axis is pivotal in the pathogenesis of ankylosing spondylitis (AS), with gut dysbiosis and mucosal immune activation driving skeletal pathology. However, translating these mechanistic insights into effective therapies remains challenging. This review critically analyzes this translational gap, arguing that the therapeutic paradoxes seen with cytokine inhibitors and microbiome-targeted therapies are a direct consequence of the disease's significant variability. We focus on the unexpected failure of IL-23 inhibitors and the dual effects of IL-17 blockade to illustrate the need for a nuanced understanding of tissue-specific immunity. We then propose a biomarker-driven, AI-assisted therapeutic framework that integrates multi-omic data to personalize AS treatment, aiming to bridge the gap between mechanistic insights and clinical success and offer a path toward progression-free remission.
- Open Access
- 2 October 2025
- Published by Wiley in Immunology
- Vol. 176 (4) , 409-420
Exhaustion‐Resistant CD8 + T Cells in Ankylosing Spondylitis: A Proposed Three‐Axis Model
Ankylosing spondylitis (AS) is a chronic immune‐mediated disease marked by sustained joint inflammation and aberrant bone remodelling. Although chronic antigen exposure usually enforces terminal exhaustion, emerging evidence indicates that a subset of CD8 + T cells in AS evades canonical exhaustion programmes while expressing programmed cell death protein 1 (PD‐1). These exhaustion‐resistant cells retain effector function and likely contribute to persistent tissue inflammation and structural damage. In this review, we dissect the cellular and molecular basis of exhaustion resistance in AS CD8 + T cells and focus on the convergence of intermittent T cell receptor (TCR) stimulation, metabolic adaptation that preserves mitochondrial fitness, and co‐stimulatory inputs from interleukin‐15 (IL‐15) and CD28. We propose an integrated three‐axis model governing CD8 + T cell fate and functional persistence in the AS context shaped by human leukocyte antigen‐B27 (HLA‐B27) and the gut–joint axis. Clarifying these mechanisms refines current views of T cell dysfunction in chronic inflammation and highlights therapeutic strategies aimed at reprogramming pathogenic immunity in AS.
- 2 October 2025
- Published by Wiley in Immunology
- Vol. 176 (4) , 409-420
Open AccessExhaustion‐Resistant CD8 + T Cells in Ankylosing Spondylitis: A Proposed Three‐Axis Model
Ankylosing spondylitis (AS) is a chronic immune‐mediated disease marked by sustained joint inflammation and aberrant bone remodelling. Although chronic antigen exposure usually enforces terminal exhaustion, emerging evidence indicates that a subset of CD8 + T cells in AS evades canonical exhaustion programmes while expressing programmed cell death protein 1 (PD‐1). These exhaustion‐resistant cells retain effector function and likely contribute to persistent tissue inflammation and structural damage. In this review, we dissect the cellular and molecular basis of exhaustion resistance in AS CD8 + T cells and focus on the convergence of intermittent T cell receptor (TCR) stimulation, metabolic adaptation that preserves mitochondrial fitness, and co‐stimulatory inputs from interleukin‐15 (IL‐15) and CD28. We propose an integrated three‐axis model governing CD8 + T cell fate and functional persistence in the AS context shaped by human leukocyte antigen‐B27 (HLA‐B27) and the gut–joint axis. Clarifying these mechanisms refines current views of T cell dysfunction in chronic inflammation and highlights therapeutic strategies aimed at reprogramming pathogenic immunity in AS.
- Open Access
Contradictory Mechanisms of rheumatoid arthritis and hepatitis B virus infection activation